Jeffrey H. Murray

Array ( [id] => 6102852 [patent_doc_number] => 20110166345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'THIAZOLYL-PYRAZOLOPYRIMIDINE COMPOUNDS AS SYNTHETIC INTERMEDIATES AND RELATED SYNTHETIC PROCESSES' [patent_app_type] => utility [patent_app_number] => 13/063226 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4251 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166345.pdf [firstpage_image] =>[orig_patent_app_number] => 13063226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6378149 [patent_doc_number] => 20100081660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Novel Compounds Having Selective Inhibiting Effect at GSK3' [patent_app_type] => utility [patent_app_number] => 12/568237 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15183 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081660.pdf [firstpage_image] =>[orig_patent_app_number] => 12568237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427703 [patent_doc_number] => 08703778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Heterocyclic kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/121157 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61708 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6359221 [patent_doc_number] => 20100087396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Novel Compounds Having Selective Inhibiting Effect at GSK3' [patent_app_type] => utility [patent_app_number] => 12/568266 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17968 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087396.pdf [firstpage_image] =>[orig_patent_app_number] => 12568266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6235007 [patent_doc_number] => 20100266711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'THIENOBENZODIAZEPINE MODULATORS OF D1 RECEPTOR, D2 RECEPTOR, AND/OR 5-HT2 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/565836 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13212 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266711.pdf [firstpage_image] =>[orig_patent_app_number] => 12565836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280963 [patent_doc_number] => 20100119624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'BENZISOXAZOLE MODULATORS OF D2 RECEPTOR AND/OR 5-HT2A RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/561646 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12067 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119624.pdf [firstpage_image] =>[orig_patent_app_number] => 12561646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189970 [patent_doc_number] => 20110172254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'FOLATE RECEPTOR BINDING CONJUGATES OF ANTIFOLATES' [patent_app_type] => utility [patent_app_number] => 13/063889 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17147 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172254.pdf [firstpage_image] =>[orig_patent_app_number] => 13063889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663688 [patent_doc_number] => 20110312957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'IMIDAZOPYRIDINES AND IMIDAZOPYRIMIDINES AS HIV-I REVERSE TRANSCRIPTASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/119431 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32494 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312957.pdf [firstpage_image] =>[orig_patent_app_number] => 13119431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189972 [patent_doc_number] => 20110172256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/063820 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34770 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172256.pdf [firstpage_image] =>[orig_patent_app_number] => 13063820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307155 [patent_doc_number] => 20100069396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => '4-AMINO-3-(IMIDAZOLYL)-PYRAZOLO[3,4-D]PYRIMIDINES' [patent_app_type] => utility [patent_app_number] => 12/557428 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14318 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069396.pdf [firstpage_image] =>[orig_patent_app_number] => 12557428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140881 [patent_doc_number] => 20120094975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'PYRIDO [5, 4-D] PYRIMIDINES AS CELL PROLIFERATION INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/062058 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27270 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094975.pdf [firstpage_image] =>[orig_patent_app_number] => 13062058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102628 [patent_doc_number] => 20110166121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'FUSED HETEROCYCLIC COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/059832 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 144353 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166121.pdf [firstpage_image] =>[orig_patent_app_number] => 13059832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099876 [patent_doc_number] => 08563755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediates' [patent_app_type] => utility [patent_app_number] => 13/062728 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4608 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189966 [patent_doc_number] => 20110172250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'ISOTOPICALLY ENRICHED PYRIMIDIN-5-YL ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/061921 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14696 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172250.pdf [firstpage_image] =>[orig_patent_app_number] => 13061921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398409 [patent_doc_number] => 20090318472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'AMINOPYRAZINE DERIVATIVES AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/546213 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18851 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318472.pdf [firstpage_image] =>[orig_patent_app_number] => 12546213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163264 [patent_doc_number] => 20110160227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Prolyl Hydroxylase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/059478 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8780 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160227.pdf [firstpage_image] =>[orig_patent_app_number] => 13059478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375189 [patent_doc_number] => 20100075989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Novel Compounds Having Selective Inhibiting Effect at GSK3' [patent_app_type] => utility [patent_app_number] => 12/545213 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6199 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075989.pdf [firstpage_image] =>[orig_patent_app_number] => 12545213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375245 [patent_doc_number] => 20100075996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'PYRROLO[2,3-D]PYRIMIDINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/542451 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10600 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075996.pdf [firstpage_image] =>[orig_patent_app_number] => 12542451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729764 [patent_doc_number] => 08101613 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => '6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/540047 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 137196 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101613.pdf [firstpage_image] =>[orig_patent_app_number] => 12540047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675522 [patent_doc_number] => 08383635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Chemical compounds' [patent_app_type] => utility [patent_app_number] => 13/058251 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28974 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058251 [rel_patent_id] =>[rel_patent_doc_number] =>)